Skip to main content
. 2015 Mar 28;15:303. doi: 10.1186/s12889-015-1656-y

Table 4.

Measurement overview

Experimental conditions Control condition
Measure Instrument T0 T1 T2 T3 T0 T1 T2 T3
Socio-demographics and disease-related characteristics
Socio-demographics of the partner Sex, age, education, marital status, cultural background, children, work status X X
Disease-related variables of the patient Sort of cancer, time of diagnosis, past and current treatment, current situation (prognosis) X X
Outcome measures
Psychological distress HADS total X X X X X X X X
Mental health MHC-SF X X X X X X X X
Caregiver strain CSI X X X X X X X X
General health RAND 36 X X X X X X X X
Health-related quality of life EuroQol EQ-5D
Mediators
Psychological flexibility AAQ-II X X X X X X X X
Self-compassion SCS-SF X X X X X X X X
Posttraumatic growth PTGI-SF X X X X X X X X
Resilience BRS X X X X X X X X
Sense of mastery Pearlin Mastery Scale X X X X X X X X
Support behavior Active engagement scale X X X X X X X X
Evaluation
Client satisfaction CSQ-8 X X
Evaluation form X X
Economic evaluation
Healthcare consumption TiC-P X X X X
Production loss due to illness and absenteeism PRODISQ X X X X
Screening 1
Depression/anxiety (optional screening) MINI (part: A, B, C, D, E, F, G, H, I, J, P) X X
Severity of symptoms SDS X X

1The MINI and SDS will only be administered in people who have moderate scores on HADS-A and/or HADS-D (score 11 - 14 on HADS-A and/or HADS-D).